This site uses cookies. Cookies remember your actions and preferences to provide the best user experience.
We strive to make healthcare more transparent and efficient by providing accurate and timely pharmaceutical market analytics to all industry participants – from manufacturers to regulators.
IQDATA
Innovation
Analytics
Accuracy
About Us
At the core of IQDATA's operations are fully localized international practices that we enhance with our own deep expertise. This empowers us to deliver analytical solutions that provide a comprehensive, multi-faceted view of the pharmaceutical industry.
IQDATA services are the synergy of advanced technologies, accuracy and profound understanding of the industry specifics. We develop and evolve digital products based on our proprietary technologies for collecting, processing and analyzing Big Data in the pharmaceutical sector.
Driven by rigorous development standard and strict data quality controls, our products and services equip industry stakeholders with the insights needed for evidence-based decision-making and sustainable growth.
IQDATA services are the synergy of advanced technologies, accuracy and profound understanding of the industry specifics. We develop and evolve digital products based on our proprietary technologies for collecting, processing and analyzing Big Data in the pharmaceutical sector.
Driven by rigorous development standard and strict data quality controls, our products and services equip industry stakeholders with the insights needed for evidence-based decision-making and sustainable growth.
Transparent analytics for considered decision making
IQDATA's analytical and information services deliver reliable outcomes, enabling you to make strategic decisions with confidence.
IQDATA technological IT-platform
All products are built on a software platform featuring a web-based data interface, visualization and reporting tools, an API for integration with external systems and robust data access control mechanisms.
Full compliance with Russian standards and business interests
IQDATA operates in accordance with Russian legal requirements, security standards and the interests of corporate clients.
Our history
1994–1999
The advent of analytical agencies in the Russian pharmaceutical market (IMS, RMBC, Pharmexpert etc)
2008–2016
Acquisition of key analytical agencies by IMS (RMBC, Pharmexpert, Cegedim)
> Introduction of international standards of analytical databases production and data processing
> Implementation of global classification systems
> Implementation of global classification systems
2008–2025
New products development
and launch:
2013 – Regional reimbursement
2014 – Sell-Out
2016 – Full-cycle market research
2018 – Sell-Out Weekly
2022 – E-commerce
and launch:
2013 – Regional reimbursement
2014 – Sell-Out
2016 – Full-cycle market research
2018 – Sell-Out Weekly
2022 – E-commerce
> Internal technical processes enhancement
> Regional granularity improvement
> Panel expansion
> DAP decrease
> Production methodology improvement
> Premium Client Service support
> Regional granularity improvement
> Panel expansion
> DAP decrease
> Production methodology improvement
> Premium Client Service support
2026
Russian business localization (IQDATA)
> Development of new regions
> Focus on new product launches
> Focus on new product launches
Our products
Retail audits
Sell-in and sell-out audits of drugs and dietary supplements in the Russian Federation with detailed sales data down to the SKU level at a deep level of territorial granularity.
Analysis of retail drug (Rx/OTC), food supplements and additional assortment sales in Russia. Processing, structuring, and extrapolation of sales data for drugs, food supplements and additional assortment within the pharmacy segment.
Analysis of retail drug (Rx/OTC), food supplements and additional assortment sales in Russia. Processing, structuring, and extrapolation of sales data for drugs, food supplements and additional assortment within the pharmacy segment.
Public Audits
Databases enabling public procurement market tracking with regional-level granularity.
Public Procurement Analytics System: Processing and structuring of government program procurement data using ETL processes and advanced data cleansing algorithms.
Public Procurement Analytics System: Processing and structuring of government program procurement data using ETL processes and advanced data cleansing algorithms.
Market research
A wide range of qualitative and quantitative studies that help to better understand the behavior of doctors, pharmacists, and patients, assess brand and category perception, as well as the effectiveness of communications and marketing activities.
Retail audit of Drugs and FS in RF (Sell-In): Analytical database of pharmacy organizations procurement. Report generation utilizes advanced data extrapolation and normalization algorithms applied to the pharmacy panel. Data is available with monthly or quarterly updates, detailed down to the SKU level.
Pharmatrend of Drugs and FS in RF (Sell-Out): Analytical database of pharmacy sales provides analysis of actual end-consumer consumption at pharmacies across Russia. The audit employs machine learning models for weighted data extrapolation, ensuring high accuracy and representativeness. The data is available with monthly updates and granularity down to the SKU level.
Pharmatrend of Drugs and FS in RF: weekly (Sell-Out): Analytical database of pharmacy sales enables analysis of actual end-consumer consumption at pharmacies across Russia. A high-frequency data processing system with a shortened update cycle, providing operational analytics for pharmacy sales in Russia.
Pharmatrend of Drugs and FS in RF: E-commerce (Sell-Out): Digital analysis module for online sales of drugs, food supplements and additional assortment categories in the Russian Federation. Integration of data from e-commerce channels, extrapolation to the total universe. Data is available with monthly updates and regional breakdown.
Pharmatrend of Drugs and FS in RF: offline (Sell-Out): Analytical database designed exclusively for tracking offline sales. Data is available with monthly updates and regional breakdown.
Retail Audits
Budget Audit (excl. DLO & RLO): Analytical database tracking procurement for hospitals, national and regional target programs, and departmental purchases. Data is available with monthly updates and regional granularity.
Audit of Federal reimbursement of drugs in RF (VZN/ONLS): Analytical database containing information on drug procurement for special patient categories (Programs for 14 Nosologies and the ONLS). Audit with monthly updates and regional breakdown.
Audit of Regional reimbursement of drugs in RF: Analytical database that tracks the procurement of drugs under regional reimbursement (in accordance with Government Decree No. 890). Data is available with monthly updates and regional breakdown.
Tender audit of Drugs and FS in RF: tenders, contracts, plans of purchases: Analytical database containing information on tenders, contracts and plans of purchases for drug supply. Data is updated in near real-time and detailed down to the healthcare facility level.
Public Audits
Brand performance audit – penetration, positioning, pricing, patient profile and promotional channels: Smart Brand, Diary Research, Digital Index, Price study, KOL mapping
Patient Category and Pathway Analysis – From diagnosis to treatment: U&A/ATU, Segmentation, Patient pathway and routing
Communication and concept test etc: Packaging test, Concept test, Advertising communications testing
Consumer behavior and trade marketing effectiveness assessment: Visibility check, Shopper/Pharma Scan, Mystery shopper, E-com digest
Company Image and Perception Assessment: Company Reputation Index
Market research
Competitive advantages
Individual approach
Each client is assigned a personal client service manager who provides comprehensive support and prompt resolution of any issues.
The IQDATA client service management team has extensive experience and deep expertise, ensuring a high standard of service and maximum interaction efficiency.
The IQDATA client service management team has extensive experience and deep expertise, ensuring a high standard of service and maximum interaction efficiency.
IQDATA Technological IT-Platform
All databases are provided in a user-friendly online environment, including a web interface for working with data, visualization and reporting tools, an API for integration with external systems, and data access management mechanisms.
Unique methodology for collecting, processing, and analyzing data
IQDATA uses a reliable methodology that ensures high accuracy and transparency of the data provided. The universe is updated twice a year, taking into account all significant changes in the structure of the pharmaceutical market.
IQDATA Reference Books
The company's unique classifications and indicators enable deep-dive market analytics and significantly enhance research productivity:
- Market Segmentation – segmentation of drugs by patent protection status to support strategic portfolio decision-making.
- Consumer Healthcare – segmentation of OTC and parapharmaceutical products, including the OTC, NTR (nutrition), PAC (patient care) and PEC (personal care) categories.
- Drug Type – type of drug (original, biosimilar, generic, hybrid, etc.) using pharmaceutical analytics and IT solutions.
- Calculated metrics (CU, SU) – analytical tools where CU (Counting Units) normalizes packaging data, and SU (Standard Units) measures consumption in standardized doses.
- WHO ATC (World Health Organization Anatomical Therapeutic Chemical) – systematization of medicinal products according to the Anatomical Therapeutic Chemical classification system by the World Health Organization.
- EphMRA (European Pharmaceutical Market Research Association) – standardized grouping for comparing drug sales data within marketing research frameworks
- NFC (New Form Code) – classification and coding of dosage forms.
- Strategic Drug List – prioritization of drugs to ensure national biosecurity, facilitate state support allocation and manage strategic reserves.
Data security
IQDATA ensures a high level of data security and reliability, guaranteeing absolute confidentiality.
IQDATA operates in accordance with Russian requirements, standards, internal policies in the areas of compliance and ethical business conduct, including anti-corruption practices, transparency in interactions with partners and adherence to corporate responsibility standards.
IQDATA operates in accordance with Russian requirements, standards, internal policies in the areas of compliance and ethical business conduct, including anti-corruption practices, transparency in interactions with partners and adherence to corporate responsibility standards.
Full-cycle market research
IQDATA conducts full-cycle marketing research. With the team of experienced specialists, we conduct high-quality projects ensuring exceptional expertise.
We specialize exclusively in the pharmaceutical market, guaranteeing deep understanding of the industry.
We specialize exclusively in the pharmaceutical market, guaranteeing deep understanding of the industry.
Our Team
The strength of our team lies in every member. Our people are experts with profound market knowledge, years of experience and unique capabilities in the healthcare and IT-solutions. Together we design solutions that deliver significant value to our partners and drive outstanding results.
- More than 20 years of experience in sales and consulting in the pharmaceutical market, including work at leading analytical companies.
- Leading the sales department in Russia and CIS (IMS, IQVIA) since 2012, responsible for business development and implementation of projects for key clients in consulting, analytical data and technology solutions.
- Regular speaker at industry conferences, invited lecturer at leading universities (ITMO, MIPT, HSE, Skolkovo).
- Education: Moscow State Academy of Chemical Technology named after M.V. Lomonosov, Candidate of Economic Sciences, MBA (AIBEC).
Svetlana Nikulina
Sales director, IQDATA
- Over 20 years of experience in the pharmaceutical market.
- Has been managing the production of analytical databases since 2011 (IMS, IQVIA) developing and advancing methodology and quality standards.
- Previously, head of the statistical data processing department and integration manager during company merges.
- Experience at Moscow State University and the Accounts Chamber of the Russian Federation, participation in international research projects on mathematical modeling and optimal control.
- Education: Faculty of Mechanics and Mathematics, Moscow State University, PhD in Physics and Mathematics.
Klavdia Izmodenova
Head of the Analytical Database Production Department, IQDATA
- Over 15 years of experience in the pharmaceutical market.
- Head of Retail Database Production since 2018 (IMS, IQVIA).
- Experience in producing databases for the Russian Federation, CIS and Georgia, additional assortment, methodology development.
- Education: RUDN University, Faculty of Physics and Mathematics, Mathematics.
Ekaterina Scherbakova
Head of Retail Database Production, IQDATA
- Over 20 years of experience in the development and implementation of information and analytical systems and business process automation, data collection and processing, including pharmaceutical industry experience.
- Head of Budget Database Production since 2018 (IQVIA).
- Education: Zhukovsky Air Force Engineering Academy (Computer Science and Automated Systems Software), Tambov State Technical University (Management).
Yuri Kholodnyakov
Head of Budget Database Production, IQDATA
Natalia Zorina
Head of Client Service Department, IQDATA
- Over 25 years of experience in the pharmaceutical industry, including work on manufacturers’ side.
- Has been managing the IMS database client service (IQVIA) since 2009 and became the Director of Client Service for the Technology and Information Services of IQVIA in 2023.
- Education: MIEM HSE, Software Engineer.
- Over 25 years of experience in the pharmaceutical industry.
- Managed the creation of reference books and the processing of primary data at IMS Health (IQVIA) since 2000, developed reference books for the Russian Federation, CIS and Mongolia, worked on the harmonization and implementation of international classifications (WHO ATC, EphMRA, NFC, CHC).
- Author of science articles and the educational portal Pharmznanie.ru.
- Education: Sechenov First Moscow State Medical University (Pharmacy), additional higher education in economics.
Olga Schagina
Head of Reference Book Management and Data Integration Department, IQDATA
- Over 25 years of experience in market research, including 15+ years in the pharmaceutical industry.
- Has been developing the qualitative research department at IMS (IQVIA) since 2016.
- Education: Lomonosov Moscow State University, Sociologist. Additional education at the Moscow Institute of Psychoanalysis and Erickson Coaching International.
Maria Bashkirova
Head of Qualitative Research, IQDATA
- Over 20 years of experience in quantitative research, including about 15 years in the pharmaceutical industry.
- Has been developing the quantitative research department at IMS Health (IQVIA) since 2016. Head of quantitative research on the pharmaceutical and medical markets since 2019.
- Work experience at GfK, MASMI, and COMCON.
- Education: Lomonosov Moscow State University, International Humanitarian and Linguistic Institute, Linguist.
Marina Ivankova
Head of Quantitative Research, IQDATA
- Over 20 years of experience in IT, information security and business process management in the pharmaceutical and life science industries.
- Since 2005 at IQVIA: integration of companies as part of M&A transactions, modernization and standardization of IT services, ensuring compliance with personal data requirements, implementation of BCP/DRP, and improvement of operational efficiency through Lean initiatives.
- Education: RTU MIREA, ITIL, MCSA Security+, Lean Manager/Facilitator certifications, invited expert at NTU Sirius.
Dmitriy Manushin
Head of IT Department, IQDATA
80%
of the Top-100 pharmaceutical companies work with IQDATA on a regular basis
25
top companies have been working with us for over 25 years
>30
years of advanced solutions for the Russian pharmaceutical market
>130
companies trust our expertise
Innovation
Analytics
Accuracy
Analytics
Accuracy
Contacts
Address
115184, Moscow, inner territory of the Zamoskvorechye municipal district, 1st Novokuznetsky Lane, Building 13, Room 1P
All-Russian Classifier of Economic Activities Code: 63.11.
The Company operates in the field of information technology.
According to Order No. 449 of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation dated May 11, 2023, the Company carries out the following activities (code):
2.01. Implementation of computer programs and databases (including updates and modifications), granting rights (licensing), and providing remote access via information and telecommunications networks, including the Internet.
3.01. Activities related to the creation of databases and information resources (including the development of concepts, structure, and composition of databases), the formation and maintenance of databases (including the collection of data from one or more sources, as well as data entry, verification, and updating), database administration (including providing access to the database via direct or telecommunications access), data retrieval, selection, and sorting based on requests, and the provision of selected data to users.
Based on Government Decree No. 1729 of the Russian Federation dated 30 September 2022 “On Approval of the Regulations on State Accreditation of Russian Organizations Operating in the Field of Information Technologies”, Decision No. AO‑20260706‑40379206348‑3 dated 20 July 2026 has been issued to grant state accreditation to LLC “IQ DATA” as an organization operating in the field of information technologies.
Registration number in the Register of Accredited Organizations: 105240
Decision number on state accreditation: AO‑20260706‑40379206348‑3
The cost of access to information products is a commercial secret.
The price is determined by the content and volume of the databases and analytical tools.
To accurately calculate the cost of access, please contact the customer service of “IQ DATA” LLC at info@iq-data.ru or by phone
The Company operates in the field of information technology.
According to Order No. 449 of the Ministry of Digital Development, Communications and Mass Media of the Russian Federation dated May 11, 2023, the Company carries out the following activities (code):
2.01. Implementation of computer programs and databases (including updates and modifications), granting rights (licensing), and providing remote access via information and telecommunications networks, including the Internet.
3.01. Activities related to the creation of databases and information resources (including the development of concepts, structure, and composition of databases), the formation and maintenance of databases (including the collection of data from one or more sources, as well as data entry, verification, and updating), database administration (including providing access to the database via direct or telecommunications access), data retrieval, selection, and sorting based on requests, and the provision of selected data to users.
Based on Government Decree No. 1729 of the Russian Federation dated 30 September 2022 “On Approval of the Regulations on State Accreditation of Russian Organizations Operating in the Field of Information Technologies”, Decision No. AO‑20260706‑40379206348‑3 dated 20 July 2026 has been issued to grant state accreditation to LLC “IQ DATA” as an organization operating in the field of information technologies.
Registration number in the Register of Accredited Organizations: 105240
Decision number on state accreditation: AO‑20260706‑40379206348‑3
The cost of access to information products is a commercial secret.
The price is determined by the content and volume of the databases and analytical tools.
To accurately calculate the cost of access, please contact the customer service of “IQ DATA” LLC at info@iq-data.ru or by phone
© IQDATA, 2026
The rights to this material belong to IQDATA, and any use of this material (or its individual parts) must be approved by IQDATA.
The rights to this material belong to IQDATA, and any use of this material (or its individual parts) must be approved by IQDATA.
Limited Liability Company «IQ DATA»
Primary State Registration Number (OGRN) 1087746654060, Taxpayer Identification Number (INN) 7724662555
Primary State Registration Number (OGRN) 1087746654060, Taxpayer Identification Number (INN) 7724662555